← Eichor
Condition: Hair Thinning Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hair Thinning

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Sever
Phase 3 · 282 location(s) · AbbVie · NCT06012240Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
NA · 2 location(s) · Cooler Heads Care Inc. · NCT05484973Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
Phase 4 · 1 location(s) · Wake Forest University Health Sciences · NCT04207931Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia
NA · 1 location(s) · Fujian Medical University Union Hospital · NCT07373054Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia
NA · 1 location(s) · Kasr El Aini Hospital · NCT07502976A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.
Phase 1 · 6 location(s) · Forte Biosciences, Inc. · NCT07205159Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indi
NA · 1 location(s) · St. Jude Children's Research Hospital · NCT04764357Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia
Phase 1/Phase 2 · 4 location(s) · Absci Pty Ltd. · NCT07317544CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
Phase N/A · 1 location(s) · CorEvitas · NCT06562270Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
Phase 3 · 13 location(s) · Industrial Farmacéutica Cantabria, S.A. · NCT05888922A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan W
Phase 3 · 15 location(s) · AbbVie · NCT07023302A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia
NA · 1 location(s) · Wake Forest University Health Sciences · NCT04764331Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
EARLY_Phase 1 · 1 location(s) · Shanghai Zhongshan Hospital · NCT07012486Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)
NA · 1 location(s) · Acorn Biolabs Inc. · NCT07107841Study of EPI-001 in Patients With Androgenetic Alopecia
Phase 1/Phase 2 · 1 location(s) · Epibiotech · NCT07618195Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Can
EARLY_Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT05417308Serum Ferroptosis Biomarkers (GPX4, MDA) in Alopecia Areata
Phase N/A · 1 location(s) · Istanbul Training and Research Hospital · NCT07733063Regeneron AA Multicenter (Dupilumab)
Phase 2 · 3 location(s) · Emma Guttman · NCT05551793Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of
NA · 1 location(s) · Zagazig University · NCT06327581Deucravacitinib in the Treatment of Cicatricial Alopecias
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07508488A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes
Phase 1/Phase 2 · 1 location(s) · Shenzhen People's Hospital · NCT07203599CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
Phase N/A · 1 location(s) · CorEvitas · NCT05745389A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia
Phase 1/Phase 2 · 1 location(s) · Olix Pharmaceuticals, Inc. · NCT07327359Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
Phase 3 · 1 location(s) · Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. · NCT07080931Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients
Phase 1/Phase 2 · 1 location(s) · PT. Prodia Stem Cell Indonesia · NCT07429253Clinical Study to Evaluate the Improvement in Hair Loss in Skin of Color Treated With Fractional Non-Ablative Laser
NA · 1 location(s) · Lumenis Be Ltd. · NCT06885112Non-Ablative Laser to Treat Scarring Alopecia With Hair Follicle Gene Expression Analysis
NA · 1 location(s) · Montefiore Medical Center · NCT06946550A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo
Phase N/A · 116 location(s) · AbbVie · NCT07136467A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.
Phase N/A · 1 location(s) · Pfizer · NCT07152119Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areat
NA · 1 location(s) · Universidad Autonoma de Nuevo Leon · NCT06564805
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.